IP Library Granted Patent US 7,235,524
Granted Patent B2
US 7,235,524 · App. 10/140,819 · Granted Jun 26, 2007

Medicaments for initiating ovulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,235,524
App. No.
10/140,819
Granted
Jun 26, 2007
Kind
B2
Abstract

The invention relates to medicaments for initiating ovulation comprising LH in an administrable form which ensures an increase in LH plasma levels for a period of some 40 to 60 hours.

Claims (12)

1. A composition for initiating ovulation, comprising luteinizing hormone in a range of 10,000 to 25,000 I.U. in an administrable form, wherein administration of the composition reproduces the physiological peak of approximately 48 hours.

2. A composition according to claim 1 , further comprising follicle stimulating hormone.

3. A composition according to claim 2 , wherein at least one of the luteinizing hormone and the follicle stimulating hormone is selected from the group consisting of an endogenous hormone and its subunits, a recombinant hormone and its subunits, a hormone analogue, and a hormone agonist.

4. A composition according to claim 1 , wherein the composition is in the form of particles of approximately 1 to 250μ.

5. A composition according to claim 4 , wherein the particles are based on a concentrate of luteinizing hormone and, optionally, follicle stimulating hormone.

6. A composition according to claim 5 , wherein the composition is stabilized using sucrose and/or salts of dicarboxylic acids.

7. A composition according to claim 4 , wherein the particles comprise a solid envelope enclosing the luteinizing hormone, said luteinizing hormone optionally associated with follicle stimulating hormone and/or a pharmaceutical excipient.

8. A composition according to claim 7 , wherein the envelope is prepared from biodegradable polymers.

9. A composition according to claim 8 , wherein the biodegradable polymers are selected from the group consisting of polylactic acid, a copolymer of lactic acid, and glycolic acid.

10. A composition according to claim 8 , wherein the particles comprise a continuous matrix of supporting material within which the luteinizing hormone, optionally associated with follicle stimulating hormone, is dispersed.

11. A composition according to claim 2 , wherein the composition is in the form of particles of approximately 1 to 250μ.

12. A composition according to claim 3 , wherein the composition is in the form of particles of approximately 1 to 250μ.

Assignments (2)
CHANGE OF NAME Recorded Dec 3, 2009
From: LABORATOIRES SERONO SA
To: MERCK SERONO SA
Reel/Frame 023602/0293 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2007
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: LABORATOIRES SERONO SA
Reel/Frame 019966/0026 →